nonneoplastic gastric disclosure statement endocrine lesions)following therapy for gastric antral...

29
Nonneoplastic Gastric Pathology (Will cheat a Bit and Include Endocrine Lesions) Elizabeth Montgomery Disclosure Statement Dr. Montgomery reports no relevant financial relationships with commercial interests. Stomach! We will begin with a whirwind tour of the things that we can encounter in gastric biopsies and then review a focused case with differential diagnosis First, a few pitfalls A Few Benign Pitfalls Crushed mucosa with sloughed mucous neck cells Erosive gastritis/gastropathy including iron pill gastritis “Signet cell change” Gastric Xanthoma Pitfall – erosive gastropathy – note that the reparative glands respect the muscularis mucosae border.

Upload: others

Post on 31-Jul-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Nonneoplastic Gastric Pathology

(Will cheat a Bit and Include Endocrine Lesions)

Elizabeth Montgomery

Disclosure Statement

Dr. Montgomery reports no relevant financial relationships with commercial interests.

Stomach! We will begin with a whirwind tour of the things that we can encounter in gastric biopsies and then review a focused case with differential diagnosis

First, a few pitfalls

A Few Benign Pitfalls Crushed mucosa with sloughed mucous neck cells Erosive gastritis/gastropathy including iron pill gastritis “Signet cell change” Gastric Xanthoma

Pitfall – erosive gastropathy – note that the reparative glands respect the muscularis mucosae

border.

Page 2: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Pitfall - Iron pill gastritis with reactive changes

Pitfall - Iron pill gastritis with reactive changes

Pitfall - Iron pill gatritis with reactive changes – iron stain

Pitfall - signet cell change in ischemic columnar mucosa; cells lose their cohesion and

slough into the lumen whilst rounding up

Pitfall - signet cell change in ischemic columnar mucosa; cells

retain E-Cadherin expression

Remember that signet cell change is very different from the in situ signet ring cell cancers in patients with CDH1 (the gene encoding for e-cadherin) germline mutations

Page 3: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Pitfall – crushed mucosa with prominent mucus neck cells – note the the sloughed

single cells are not within lamina propria but floating and seen in gland lumina

Pitfall – crushed mucosa with prominent mucus neck cells – note the the sloughed

single cells are not within lamina propria but floating and seen in gland lumina

Pitfall – crushed mucosa with

prominent mucus neck cells –

note the the sloughed

single cells are not within

lamina propria but floating

and seen in gland lumina

Pitfall – crushed mucosa with

prominent mucus neck cells – note

the sloughed

single cells are seen in gland

lumina – oil immersion (bad idea)

The real thing – signet cell

carcinoma - the bad cells are firmly

in the lamina propria so not seen

in the lumina

Page 4: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Gastric xanthoma

Gastric xanthoma, PAS

And now a whirlwind of things we encounter on biopsies .. Some rare and some common

Mucosal calcinosis – seen in patients with renal failure or other disorders of calcium metabolism such as parathyroid adenomas

Calcium pill gastritis – same pattern with doxycycline

Page 5: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Proto pump inhibitor effect

Sarcina ventriculi Patient with diabetes and slow gastric emptying – note exudate and organisms at low power

Sarcina ventriculi Sarcina ventriculi gastritis

Gram positive, anaerobic, sugar-fermenting

bacterium, S. ventriculi was first observed in

the human stomach in 1842 by Goodsir .

Readily found in soil and is known to cause

a similar type of gastric injury in animals.

Delayed gastric emptying and carbohydrate

stasis in association with acidic gastric

juices may provide an ideal culture medium

Sarcina Ventriculi gastritis

Studied patients all had underlying delayed gastric

emptying (one had a bezoar) from diabetic

neuropathy, narcotic use, and pyloric stenosis

secondary to malignancy

The organism may simply colonize pre-existing

lesions but there are too few cases to draw firm

conclusions as to whether the organism is truly a

pathogen.

Packets of 4, 8 or more cells with characteristic

flattening Lam-Himlin D, Tsiatis AC, Montgomery E, Pai RK, Brown JA, Razavi M, Lamps L, Eshleman JR,

Bhagavan B, Anders RA. Sarcina organisms in the gastrointestinal tract: a clinicopathologic and

molecular study. Am J Surg Pathol. 2011 Nov;35(11):1700-5.

Lymphocytic gastritis – Most common association – Celiac disease followed by H. Pylori

Page 6: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Lymphocytic gastritis – Most common association – Celiac disease followed by H. Pylori

Collagenous Gastritis

Associated with various autoimmune diseases in both children and

adults

We have seen it associated with medications (eg Benicar/Olmesartan)

Early studies proposed 2 clinicopathologic subtypes:

(1) children (18 y of age or younger) presenting with severe

anemia, nodular gastric mucosa, and isolated gastric disease; and

(2) adults with chronic watery diarrhea that is associated with

diffuse collagenous involvement of the gastrointestinal tract.

Ma C, Park JY, Montgomery EA, Arnold CA, McDonald OG, Liu TC, Salaria SN, Limketkai BN, McGrath KM, Musahl T,

Singhi AD. A Comparative Clinicopathologic Study of Collagenous Gastritis in Children and Adults: The Same Disorder

With Associated Immune-mediated Diseases. Am J Surg Pathol. 2015 Apr 10. [Epub ahead of print] PubMed PMID:

25871617.

Collagenous gastritis – poorly understood and sometimes resolves by itself – presents with watery diarrhea just like collagenous colitis

Collagenous gastritis in gastric body. Is something missing (you betcha – parietal cells)

Collagenous gastritis associated with autoimmune gastritis

Page 7: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Collagenous gastritis

associated with

autoimmune gastritis

Collagenous gastritis associated

with autoimmune gastritis –

chromogranin stain showing

enterochromaffin like (ECL) cell

hyperplasia

Granulomatous gastritis – pattern – can

be Crohn s disease but always requires

correlation with clinical findings

Cytomegalovirus gastritis – note

that the EPITHELIAL cells are often

affected in the stomach

Cytomegalovirus gastritis – the

monocyte-rich inflammation can

mimic a lymphoma

Russell body gastritis – usually a

curious incidental findings and only

sometimes associated with plasma cell

disorders

Page 8: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Russell body gastritis, PAS/AB stain

Syphilis Gastritis

Not well studied and correlation with HIV

status is not well established in the literature

(which consists mostly of case reports)

The key is that is tends to present in young

adults with diffuse erosive gastritis or lesions

that mimic carcinoma and lymphoma

Vintage images of syphilis gastritis courtesy of the late Jack Yardley

Page 9: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Epstein Barr virus Gastritis

Epstein Barr virus gastritis – mimics lymphoma

Epstein Barr virus gastritis – mimics lymphoma

EBV in situ hybridization

EBV gastritis – note nuclear hybridization in the exuberant mixed lymphoid infiltrate

Page 10: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Measles gastritis!!!!

Measles gastritis

Measles gastritis

Case

A 68 year old woman with dyspepsia

underwent upper endoscopy and had some

gastric biopsies.

The endoscopist thought the mucosa was

atrophic and also saw a polyp.

Antrum – 68 yo woman Body

Body

Page 11: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

polyp Diagnosis

Autoimmune gastritis

Hyperplastic polyp

Esophagus, Stomach, and Duodenum:

Normal Anatomic Outlines and Relationships

Normal Antral Mucosa with Gastric Lumen (LUM),

Foveolae (FOV), and Antral Glands (AG) Indicated

H&E Mucus (PAS)

Normal Oxyntic Mucosa with Foveolae (FOV),

Parietal Cells (PC), and Chief Cells (CC) Indicated

H&E Stain Mucus Stain (PAS)

Major Endocrine Cell Types of the Stomach and

Their Products - Immunostain Demonstrations

Page 12: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

A few Comments on Helicobacter pylori

Gastritis

Two Australians win Nobel Prize in Medicine Awarded for work on peptic ulcer disease

R. Warren Pathology

B. Marshall GI Medicine & Microbiology

Helicobacter pylori: Curved Organisms (HP) with

Flagellae Over Gastric Epithelium

Light Microscopy Electron Microscopy

Variant form – Helicobacter heilmannii Reacts with H. pylri immunostain Similar clinical profile to H pylori Pediatric cases possible over-represented

Prevalence of Helicobacter pylori Infection in

Developing vs. Developed Countries

Aliment Pharmacol Ther 1995;9(Supp2):33

Page 13: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Consequences of H. pylori infection

Many are asymptomatic

“dyspepsia”

Peptic ulcer

Atrophy and intestinal metaplasia of mucosa

Increased risk for intestinal type adenocarcinoma

MALT lymphoma

Link to autoimmune gastritis in susceptible host

Duodenal and “Pre-Pyloric” Ulcers

Duodenal Ulcer with Brunner Gland (BG) Hyperplasia,

Pancreatic Penetration and Exposed Artery

Eradication of H. Pylori in Recurrent Duodenal Ulcer

NEJM 328 : 308-312, 1993

Benign Gastric Ulcer - Lesser Curve,

Transitional Zone

Antrectomy

Specimen

Environmental Metaplastic Atrophic Gastritis

•  Suspected causative factors:

- H. pylori infection

- Dietary: High salt; smoked foods; nitrates;

poor fruit and vegetable intake

- Others:

Smoking

Page 14: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

H. Pylori associated Metaplastic Atrophic Gastritis

(Stemmermann’s Technique; stained for alkaline phosphatase )

Early

Advanced

Red areas = intestinalization

H. Pylori Organisms Have Specific Affinity for Gastric

Mucous Cells But Not Intestinal Absorptive Cells

Carcinoma in Environmental Metaplastic

Atrophic Gastritis (EMAG)

Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S,

Amagai K, Hayashi S, Asaka M; Japan Gast Study Group. Effect of eradication

of Helicobacter pylori on incidence of metachronous gastric carcinoma after

endoscopic resection of early gastric cancer: an open-label, randomised

controlled trial. Lancet. 2008 Aug 2;372(9636):392-7.

Autoimmune gastritis

Metaplastic Atrophic Gastritis (MAG)

Autoimmune vs. H.pylori Types

Autoimmune H. pylori

Page 15: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Autoimmune vs. Environmental

Metaplastic Atrophic Gastritis

Autoimmune H. Pylori

Red areas = intestinalization

Autoimmune MAG (AMAG)

•  Etiology/

Pathogenesis:

- Inherited predisposition

- Autoimmune-induced damage

Parietal cell antibodies

Intrinsic factor antibody

- H. pylori organisms usually absent

•  Pathology: - Body (ONLY!)

DIFFUSE METAPLASIA; mucosa thin

Loss of oxyntic glands (“atrophy”)

- Antrum - NO METAPLASIA; hyperplasia

- Endocrine

G-cell hyperplasia

ECL cell hyperplasia

Autoimmune Metaplastic Atrophic

Gastritis (AMAG) - Autopsy Autoimmune Metaplastic Atrophic Gastritis

(AMAG) vs. Normal Mucosa

AMAG

Normal

Oxyntic

Mucosa

Oxyntic Mucosa: Autoimmune Metaplastic Atrophic

Gastritis (AMAG) -Intestinal and Pyloric Metaplasia

H&E (PAS/Alcian Blue)

•  Achlorhydria or marked hypochlorhydria

Autoimmune MAG (AMAG)

Clinical Correlations

•  B-12 malabsorption

•  Serum gastrin - high levels

•  Gastric cancer: risk increased 7 fold

•  Gastric ulcer: not a problem (no acid!)

We used to think this was a Northern European disease but it is equal opportunity

Female prevalence holds regardless of race

Page 16: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Gastric Polyps and Neoplasms Associated

with Autoimmune Gastritis

1. Hyperplastic polyps

2. Adenomas (intestinal and pyloric gland

types)

3. Gastric carcinomas

4. Well differentiated neuroendocrine

(carcinoid) tumors

Gastric Polyps

Any projection above the adjacent mucosal

surface.

reactive/inflammatory, hamartomatous, or

neoplastic in nature.

The classification of gastric epithelial polyps can

be challenging histologically, but can have

important consequences both for the clinical

management of the polyp itself as well as

implications about the remainder of the patient’s

gastric mucosa.

Gastric Polyps – Why the Fuss

Dysplastic (pathologically equivalent to neoplastic) or non-

neoplastic.

Implications of various types of polyps for the remainder of

the patient’s gastric mucosa.

Unlike colonic polyps (most of which are isolated findings in

an otherwise normal background mucosa) many gastric

polyps arise in association with either inflammatory/atrophic

gastritities or in association with inherited polyposis

syndromes.

Correct classification of gastric polyps, even innocuous-

appearing polyps, may sometimes provide important clues

as to abnormalities in the surrounding stomach.

Page 17: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Hyperplastic polyps Common gastric epithelial polyps (second most common overall after fundic gland polyps). Few mm to many cm (one hyperplastic polyp resected at Johns Hopkins was 9 cm in diameter) May be mistaken endoscopically for carcinoma.

Hyperplastic Polyps Hyperplastic polyps may arise anywhere in the stomach Slight preference for the antrum 20% multiple Considered to be non-neoplastic lesions (though many molecular alterations reported) It is unusual for hyperplastic polyps to arise in normal stomachs.

Hyperplastic Polyps - Associations

Most strongly associated with atrophic gastritis of either autoimmune or environmental (e.g., Helicobacter pylori-associated) types post-antrectomy state chemical/reactive gastropathy following therapy for gastric antral vascular ectasia (“watermelon stomach”).

Endoscopic Appearances – “Watermelon stomach”

Page 18: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Hyperplastic Polyps - Associations

Patients with hyperplastic polyps

are at an increased risk for

synchronous or metachronous

adenocarcinomas arising in the

stomach outside of the polyp.

Hyperplastic Polyps

True dysplasia arising in hyperplastic polyps is uncommon.

Dysplasia in hyperplastic polyps reported in <2% to 19% of cases in the literature

In a review of 160 patients with gastric hyperplastic polyps, we found dysplasia in only 4% .

Adenocarcinomas are occasionally reported in these polyps but this is unusual; we found adenocarcinoma within a hyperplastic in only one (0.6%) of 160 patients.

Page 19: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Dysplasia and Cancer in Hyperplastic Polyp

Dysplasia and Cancer in Hyperplastic Polyp

Hyperplastic Polyps When we diagnose a gastric hyperplastic polyp in a patient who has not had corresponding biopsies of the non-polypoid mucosa, we often add a note in the pathology report indicating that biopsies of the non-polypoid antrum and body may be helpful in further assessment.

Hyperplastic Polyps and Autoimmune Gastritis

Extensively documented association. Autoimmune gastritis is suggested histologically when biopsies show corpus-predominant gastritis, glandular atrophy, and intestinal metaplasia.

Antrum – 68 yo woman

Gastrin Stain

Page 20: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Hyperplastic polyp Body

Body

Gastrin stain

Chromogranin Stain

Page 21: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Type 1 carcinoid

arising in gastric

body of 50+ woman

with history of type

1 diabetes

The background

gastric body lacks

parietal cells

Type 1 carcinoid arising in

gastric body of 50+ woman

with history of type 1

diabetes

The flat oxyntic

mucosa

surrounding Type 1

carcinoid

ECL cell

hyperplasia

Intestinal

metaplasia

(pseudo)pyloric

metaplasia

ECL cell hyperplasia, the precursor to the

carcinoid that will never kill the patient

ECL Hyperplasia – Type 1

Carcinoids

When Does It Stop Being ECL Cell

Hyperplasia and Become Carcinoid?

Extensive useless literature on hyperplasia-

dysplasia-neoplasia involving use of

micrometers

Some use a cut-off of 0.5 mm as “carcinoid”

Our definition – if the endoscopist sees a

bump it’s a carcinoid

It is pointless to measure minute lesions –

they never hurt the patients even as full

fledged carcinoids

Page 22: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Multiple Gastric Carcinoids – sometimes antrectomy is needed to remove the source of the excess gastrin

Problems Many pathologists don’t know how to diagnose autoimmune gastritis/pernicious anemia pattern Many internal medicine/family practice colleagues have no idea that they need to give their patients vitamin B12 when the diagnostic line in the pathology report says “autoimmune gastritis” and think their patients have uncomplicated iron deficiency anemia -the high gastric pH does not allow for iron absorption Many surgery colleagues want to perform aggressive resections for such tumors

Another Type 1 carcinoid

of the gastric body. There

is no background oxyntic

mucosa

Type 1 carcinoid, Chromogranin

stain. Note the ECL cell

hyperplasia in the background

Type 1

carcinoid -

We avoid doing ki-67 stains in Type 1 carcinoids

since they are essentially always indolent and

results such as this one don t mean anything -

(metastases are rare for type 1 carcinoids and deaths are exceptional)

Page 23: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Time to Talk About Type 2

Carcinoid

Slide A is from the duodenum

and slide B is from the stomach.

What syndrome can you dream

up to explain these findings?

A

B

Page 24: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

A, gastrin stain

B, gastrin stain

Diagnosis – Zollinger-Ellison

Syndrome with a duodenal

gastrinoma and a gastric

carcinoid tumor/WDNET of

ECL cell type

Zollinger-Ellison

Page 25: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Type 3 Gastric NET

No autoimmune backdrop, no Zollinger

Ellison (no gastrinoma)

In other words, no hypergastrinemia

More aggressive than type 1 with about a

third dying of disease and metastases in

about 70%

(metastases are rare for type 1 and deaths are exceptional) data poor on type 2 but they are indolent

This lesion is easy to

diagnose as type 3

NET/carcinoid

because there is

intact oxyntic mucosa

For this lesion, we

need more

information to

subtype it – if we

know it s antral

then it is type 3

Another Type 3 carcinoid in a patient with normal serum

gastrin. The background is normal oxyntic mucosa. This lesion

is spindly and reminiscent of a gastrointestinal stromal tumor….

Page 26: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

A spindled

type 3

carcinoid

Type 3 carcinoid – note the intact parietal cells

Type 3 carcinoid – and others –

pitfall alert – note weak AE1/3

Type 3 carcinoid – Cam 5.2 saves the day….

Type 3 carcinoid –

Chromogranin stain

– No ECL cell

hyperplasia in

adjoining mucosa

True high grade gastric

neuroendocrine lesions can also

be very rarely encountered and

are most often metastases from

the lung; this was primary in

the antrum

Page 27: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Mitoses in this small

cell carcinoma are

easy to find

This is a

synaptophysin

stain

What Do We Need to Assure?

Be sure you know how to diagnose autoimmune

gastritis!!!! Many pathologists do not know how!!!!!!

We see autoimmune gastritis in about 2% of our

gastric biopsies “in house” at Johns Hopkins – if

this diagnosis is never in your path reports you are

not recognizing the pattern

We have begun to report autoimmune gastritis as

“autoimmune gastritis/pernicious anemia pattern”

with a note about risk for iron deficiency and

pernicious anemia and various tumors.

This is

Not a Carcinoid

This is Ectopic/

Heterotopic Pancreas

Hyperplastic Polyps - Ddx

1) conditions of generalized gastric

mucosal hyperplasia (Menetrier’s

disease) and/or inflammation

(Cronkhite-Canada syndrome)

2) hamartomatous polyps and

syndromes involving the stomach.

Page 28: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Ménétrier's Disease

Marked foveolar hyperplasia with abundant mucus

production

glandular atrophy

edematous but typically uninflamed lamina propria

most commonly limited to the body and fundus.

Knowledge of the endoscopic appearance of giant

folds, hypoproteinemia and peripheral edema, and

lack of intervening normal mucosa can help to

distinguish Menetrier’s disease from hyperplastic

polyp; however, the changes may be histologically

indistinguishable based on a single biopsy.

Menetrier s

Disease

Ménétrier's Disease

Hypertrophic

gastropathy

Giant folds

Hypoalbuminemia

Foveolar hyperplasia

Hypochlorohydria

Menetrier’s Disease

Pathogenesis

Overproduction of transforming growth factor alpha (TGF alpha) has been documented could account for decreased acid production, hyperplasia of surface mucous cells, oxyntic atrophy, and increased mucin production.

Transgenic mice that overproduce TGF alpha have features of Ménétrier's disease, including foveolar hyperplasia, increased mucin content

TGF alpha is one of six ligands that bind to the epidermal growth factor receptor, and increased production of any of these ligands may contribute to Ménétrier's disease.

Novel Treatment

Burdick JS, Chung E, Tanner G, Sun M, Paciga JE, Cheng JQ, Washington K, Goldenring JR, Coffey RJ.Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med. 2000 Dec 7;343(23):1697-701.

Settle SH, Washington K, Lind C, Itzkowitz S, Fiske WH, Burdick JS, Jerome WG, Ray M, Weinstein W, Coffey RJ.Chronic treatment of Ménétrier's disease with Erbitux: clinical efficacy and insight into pathophysiology. Clin Gastroenterol Hepatol. 2005 Jul;3(7):654-9.

Page 29: Nonneoplastic Gastric Disclosure Statement Endocrine Lesions)following therapy for gastric antral vascular ectasia (“watermelon stomach”). Endoscopic Appearances – “Watermelon

Thank you